John C Landgraf Net Worth

The estimated Net Worth of John C Landgraf is at least $16.7 Million dollars as of 3 June 2014. John Landgraf owns over 18,203 units of Abbott Laboratories stock worth over $9,331,922 and over the last 15 years John sold ABT stock worth over $7,359,420.

John Landgraf ABT stock SEC Form 4 insider trading

John has made over 32 trades of the Abbott Laboratories stock since 2004, according to the Form 4 filled with the SEC. Most recently John exercised 18,203 units of ABT stock worth $580,858 on 3 June 2014.

The largest trade John’s ever made was exercising 140,258 units of Abbott Laboratories stock on 31 August 2012 worth over $6,890,876. On average, John trades about 12,898 units every 56 days since 2004. As of 3 June 2014 John still owns at least 113,334 units of Abbott Laboratories stock.

You can see the complete history of John Landgraf stock trades at the bottom of the page.

What’s John Landgraf’s mailing address?

John’s mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064-6400.

Insider trading at Abbott Laboratories

Over the last 19 years, insiders at Abbott Laboratories have traded over $300,124,202 worth of Abbott Laboratories stock and bought 1,026,437 units worth $44,673,718 . The most active insider traders include Miles D White, Richard A Gonzalez, and Glenn F Tilton. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,036,946. The most recent stock trade was executed by Randel William Woodgrift on 23 October 2019, trading 21,000 units of ABT stock currently worth $1,691,340.

What does Abbott Laboratories do?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

What does Abbott Laboratories’s logo look like?

Complete history of John Landgraf stock trades at Abbott Laboratories

Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include:

• Miles White, Chairman of the Board, Chief Executive Officer
• Robert Ford, President, Chief Operating Officer
• Brian Yoor, Chief Financial Officer, Executive Vice President – Finance
• Hubert Allen, Executive Vice President, General Counsel, Secretary
• Daniel Salvadori, Senior Vice President – Established Pharmaceuticals, Latin America.
• Robert Alpern, Independent Director
• Sally Blount, Independent Director
• Glenn Tilton, Independent Director
• Samuel Scott, Independent Director
• William Osborn, Lead Independent Director
• Roxanne Austin, Independent Director
• Edward Liddy, Independent Director
• Nancy McKinstry, Independent Director
• Phebe Novakovic, Independent Director
• John Stratton, Independent Director
• Daniel Starks, Independent Director
• Michelle Kumbier, Independent Director
• Darren McDew, Director
• Jaime Contreras, Senior Vice President – Core Laboratory Diagnostics, Commercial Operations
• Jared Watkin, Senior Vice President
• Andrew H Lane, Senior Vice President
• Robert E Funck, Senior Vice President
• Sean Shrimpton, Senior Vice President
• John M Capek, Executive Vice President
• Deepak S. Nath, Senior Vice President
• Joseph J Manning, Senior Vice President
• Roger Bird, Senior Vice President
• Brian J Blaser, Senior Vice President
• Stephen R Fussell, Senior Vice President
• Michael J Warmuth, Senior Vice President
• Eric S Fain, Senior Vice President
• Lisa D Earnhardt, Executive Vice President
• Sharon J Bracken, Senior Vice President
• Michael T Rousseau, Pres., Cardiovasc. & Neuromod.
• Charles Brynelsen, Senior Vice President
• Michael J Pederson, Senior Vice President
• Alejandro D Wellisch, Senior Vice President
• Sammy Karam, Senior Vice President
• Randel William Woodgrift, Senior Vice President
• Christopher J Scoggins, Senior Vice President
• Richard W Ashley, Executive Vice President
• Andrea F Wainer, Executive Vice President
• John F Ginascol, Executive Vice President
• Jean Yves Pavee, Senior Vice President
• W James Farrell, Director
• Thomas C Freyman, Senior Vice President
• Georges H. De Vos, Senior Vice President
• Katherine C. Doyle, Senior Vice President
• J. Scott White, Senior Vice President
• Charles D Foltz, Senior Vice President
• Murthy V Simhambhatla, Senior Vice President
• Thomas G Frinzi, Senior Vice President
• John C Landgraf, Senior Vice President
• Greg W Linder, Vice President
• Heather L Mason, Senior Vice President
• Paul K Magill, Senior Vice President
• A. David Forrest, Senior Vice President
• H Laurance Fuller, Director
• Carlos Alban, Senior Vice President
• James V Mazzo, Senior Vice President
• Holger A Liepmann, Senior Vice President
• William D Smithburg, Director
• Laura J Schumacher, Senior Vice President
• David Owen, Director
• Edward L Michael, Senior Vice President
• Richard A Gonzalez, Chief Operating Officer
• Donald V Jr Patton, Senior Vice President
• William M Daley, Director
• Robert B Hance, Senior Vice President
• Mary T Szela, Senior Vice President
• Roy S Roberts, Director
• Corlis D Murray, Senior Vice President
• Thomas F Chen, Senior Vice President
• Olivier Bohuon, Senior Vice President
• James L Tyree, Senior Vice President
• W Ann Reynolds, Director
• Boone Jr Powell, Director
• Mary K Moreland, Executive Vice President
• Edward J Fiorentino, Senior Vice President
• Gary E Mccullough, Senior Vice President
• Jeffrey M Leiden, President & COO
• Jack M Greenberg, Director
• Joseph M Nemmers, Senior Vice President
• John R Walter, Director
• Jeffrey R Binder, Senior Vice President
• William G Dempsey, Senior Vice President
• A Barry Rand, Director
• Thomas M Wascoe, Senior Vice President
• Christopher B Begley, Senior Vice President
• Lance B Wyatt, Senior Vice President
• Guillermo A Herrera, Senior Vice President
• Lasa Jose M De, Senior Vice President